CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Cala Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05012579
NCT05012579N/ACompleted
CompareCT.gov

A Study of Safety and Efficacy of Transcutaneous Afferent Patterned Stimulation (TAPS) for Reduction of Action Tremor in Parkinson's Disease (PD)

Cala Health, Inc.·interventional·Posted Aug 19, 2021·Updated Feb 13, 2024

In Brief

A clinical study evaluating Cala Device for Parkinson Disease. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Demonstrate safety and efficacy of TAPS delivered by a Cala device as a treatment for action tremor in subjects with Parkinson's disease hand tremor

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 19, 2021
Enrollment StartNov 11, 2020
Primary CompletionMar 12, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.9 years ago

Interventions

Cala Devicedevice

transcutaneous afferent patterned stimulation (TAPS)